Overcoming persistent dependency on androgen signaling after progression to castration-resistant prostate cancer. (41/115)

 (+info)

Effect of decreasing intraluteal progesterone on sensitivity of the early porcine corpus luteum to the luteolytic actions of prostaglandin F2alpha. (42/115)

 (+info)

5-Androstene-3beta,7beta,17beta-triol (beta-AET) slows thermal injury induced osteopenia in mice: relation to aging and osteoporosis. (43/115)

 (+info)

Phase III data for abiraterone in an evolving landscape for castration-resistant prostate cancer. (44/115)

 (+info)

Midazolam inhibits hippocampal long-term potentiation and learning through dual central and peripheral benzodiazepine receptor activation and neurosteroidogenesis. (45/115)

 (+info)

Novel androstenetriol interacts with the mitochondrial translocator protein and controls steroidogenesis. (46/115)

 (+info)

New findings in bladder and prostate cancer: highlights from the 26th annual congress of the European Association of Urology, March 18-22, 2011, Vienna, Austria. (47/115)

At the recent annual congress, of the European Association of Urology (EAU), urologists from around the world presented their exciting discoveries related to an array of topics. Besides the huge variety of different sessions and courses, the EAU Section of Uro-Technology (ESUT) transmitted live broadcasts of surgeries from the medical universities of Vienna and Heilbronn, focusing on novel surgical techniques. Unfortunately, this year's congress was clouded by the environmental disaster and nuclear accident in Japan, which prevented a number of Japanese urologists to attend the congress due to obstacles in travelling. In this brief update, we will highlight some of the findings and the clinical significance of a few of this year's important abstracts in bladder and prostate cancer.  (+info)

Induction of mRNA for chemokines and chemokine receptors by prostaglandin F2alpha is dependent upon stage of the porcine corpus luteum and intraluteal progesterone. (48/115)

 (+info)